In the spring of 2014, after conducting an audit of resource optimization process for pharmaceutical products and services, the Acting Auditor General of Quebec (VGIQ) filed a report that denounced the variation in drug prices among certain health institutions and the lack of bidding on the part of manufacturers and questioned the practice of some health institutions in the management of the supply of drugs in case of shortages. This report by the VGIQ enabled us to better understand the bidding process for the supply of drugs in health facilities.
Not only did our research and meetings allow us to make important nuances about the conclusions reached by the Auditor General of Quebec, but also they enabled us to better identify the actual imperfections of the current bidding process.
Considering its complexity, we wished in this report, to clarify the
bidding process in order to enable the reader, whether from academic
institutions, the business community or the public at large, to consider the
benefits and disadvantages of this process in a more meaningful way. We believe
this is essential for the effective participation of these actors, that might
be required if the government wanted to modify the bidding process for the
supply of drugs within Quebec hospitals or extend it to ambulatory settings.
Center for Interuniversity Research and Analysis of Organizations
1130 rue Sherbrooke Ouest, suite 1400
Montréal, Québec (Canada) H3A 2M8
© 2019 CIRANO. All rights reserved.